COTA Partners with Google Cloud to Transform Cancer Care
New partnership focused on bringing clarity to unstructured oncology data through the latest advancements in machine learning and natural language processing
NEW YORK, Nov. 14, 2022 /PRNewswire/ -- COTA, Inc. , an oncology real-world data and analytics company, announced a new partnership with Google Cloud to develop algorithms that will extract and make sense of unstructured data from electronic health records (EHRs). The companies will apply machine learning and natural language processing to curate text fields like clinician notes, transforming them into structured fields that can be used for research and analytics.
The EHR has revolutionized the way healthcare providers capture data, but challenges related to transforming raw, unstructured health data into fit-for-purpose real-world data remains a massive challenge today. Together, COTA and Google Cloud are entering into a technology partnership to tackle this challenge head-on, with the goal of fueling a new era of transformative innovation in oncology research and cancer patient treatment.
While the vast majority of critical health data is now created and stored digitally, much of the information is still generated in an unstructured format. Free-text clinical notes and PDF documents remain largely invisible to algorithms that can mine structured data fields for key insights into patient care. As a result, clinicians and researchers may be unable to generate a complete picture of the patient's journey and could miss opportunities to advance the standard of care and treatment options.
"Imagine a scenario where we can be alerted, in real time, to new diseases or receive signals from geographies where patients are experiencing better outcomes, or poorer outcomes, so that we can take action quickly," said Miruna Sasu, President and CEO at COTA, Inc. "In order for this to become our reality, we must leverage technologies to ingest healthcare data responsibly, accurately, and expeditiously. We are delighted to partner with Google Cloud to combine our respective strengths in technology and data science with the ultimate goal of improving care for patients."
Today, many leading real-world data companies — including COTA — leverage clinicians to manually curate oncology real-world data. While this is a reliable and trusted near-term solution to overcoming the challenges associated with abstracting and curating unstructured oncology data, it makes scaling this approach across vast amounts of data both time- and resource-intensive.
In collaboration with Google Cloud, COTA will look to augment manual, human-led abstraction with technology-first abstraction and curation best practices. This approach will, over time, provide access to even more advanced data elements that may be buried in unstructured notes. For example, next-generation genomic sequencing is becoming particularly important for personalizing cancer care. However, the reports providers receive from the genetic testing labs are often in a PDF format. Traditional tools like optical character recognition (OCR) can't accurately "read" the text in these PDF images, so this data often goes unused today.
"We are collaborating with COTA to build a series of new natural language processing models tailored specifically to unstructured oncology data, including emerging data such as genomic sequencing," said Shweta Maniar, Director of Life Sciences Industry Solutions at Google Cloud. "By training these algorithms specifically on oncology information, we will partner with COTA in generating a much more complete understanding of what is happening in the cancer care setting and how a patient's unique clinical history may impact their response to treatment."
For more information on COTA and Google Cloud's efforts to help providers and researchers power the next generation of oncology treatments and evidence-based cancer care with fit-for-purpose oncology real-world data, please visit our blog .
Founded by oncologists, COTA is committed to creating a precise, patient-first approach to cancer care through the use of real-world data. The company leverages technology-supported human data abstraction methods to make sense of complex, fragmented patient data from the real world. Offering the highest quality oncology real-world data from leading academic and community-based cancer centers and an advanced analytics platform, COTA partners with leading life sciences companies, providers, and payers to ensure that everyone touched by cancer has a clear path to the right care. To learn more about COTA and how to fast-track improvements in cancer care and treatment with comprehensive and diverse real-world data and analytics, visit cotahealthcare.com .
SOURCE COTA, Inc.
Share this article